Active immunization to generate antibodies to soluble A-beta
Details for Australian Patent Application No. 2004209981 (hide)
International Classifications
Event Publications
18 August 2005 PCT application entered the National Phase
PCT publication WO2004/069182 Priority application(s): WO2004/069182
26 February 2009 Application Accepted
Published as AU-B-2004209981
21 May 2009 Assignment before Grant
Wyeth; Neuralab Limited The application has been assigned to Wyeth; Elan Pharma International Limited
25 June 2009 Standard Patent Sealed
8 April 2010 Alteration of Name
The name of the patentee has been altered to Elan Pharma International Limited; Wyeth LLC
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004209984-Immune regulation based on the targeting of early activation molecules
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser